This multi-sector collaboration compiles and compares mutagenicity datasets for NDSRIs across in vitro Ames testing and the in vivo transgenic rodent (TGR) gene mutation assay. Across 33 NDSRIs, the analysis found 79% concordance in overall mutagenic calls, providing practical evidence on when these approaches align for ...
Ames concordance with the in vivo transgenic rodent (TGR) gene mutation assay for NDSRIs and relative in vivo TGR potency with nitrosamines with robust dose-response carcinogenicity data
Regulatory Toxicology and Pharmacology, 2026



